Results

Total Results: 1,187 records

Showing results for "week".

201. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
     May 01, 2006 - Layout 1 Background Anemia (deficiency of red blood cells) occurs in 13-78 percent of patients undergoing treatment for solid tumors and 30-40 percent of patients treated for lymphoma. Tumor type, treatment regimen, and history of prior cancer therapy influence the risk and severity of anemia. For example, among pa…

202. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
     September 01, 2011 - effectiveness research review is posted to the EHC Program Web site in draft form for public comment for a 4-week … 1 and extending through the final observation at week 4. … then had successfully transitioned to maintenance antidepressant medication monotherapy during a 3 week … in favor of the active TMS treatment group compared to the sham TMS treatment group at both the week … 4 and week 6 outcome time points on the Factor Scores for Core Depression Symptoms, the Maier and

203. hemorrhage-postpartum-protocol-140611 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hemorrhage-postpartum_research-protocol.pdf
     June 11, 2014 - hemorrhage-postpartum-protocol-140611 Evidence-based Practice Center Systematic Review Protocol Project Title: Management of Postpartum Hemorrhage I. Background and Objectives for the Systematic Rev…

204. Rheumatoid-Arthritis-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
     April 01, 2012 - Low † at MTX doses ranging from 7.5 to 25 mg per week ACR = American College of Rheumatology; DMARD

205. Making Healthcare Safer IV Rapid Response_Active Surveillance Culturing of Clostridioides difficile and Multidrug-Resistant Organisms: Methicillin-Resistant Staphylococcus aureus, Carbapenem-Resistant Enterobacterales, and Candida auris (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
     May 01, 2024 - weeks before ICU admission; hematological malignancies; and immuno- suppressive treatment for >1 week

206. Appendix-Table-B-1-Observational-Studies (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-table-B-1-observational-studies.xlsx
     March 20, 2021 - Data table Appendix Table B-1. Observational studies of reinfection from SARS-CoV-2 Author Publication Year Title PMID Publication Status at Time of Report Publication Link/URL Country Study Design Length of Followup (Months) Population Category Population Description Data Source Inclusion Criteria Exclusion Crite…

207. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
     December 01, 2013 - Merck stated that the wholesale acquisition cost is about $1,100 per patient per week of treatment. … boceprevir ($117.14 per 375-mg capsule); the company set the average wholesale price at $49,200 for a 12-week … regimen, or $4,100 per week … Merck stated that the wholesale acquisition cost is about $,1100 per patient per week of treatment. … After receiving an 8-week telaprevir-based combination regimen, followed by treatment with IFN-RBV

208. Executive Summary_Systematic Review: Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-research-executive-summ.pdf
     April 01, 2025 - Executive Summary_Systematic Review: Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents Systematic Review Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents Executive Summary Main Points • When po…

209. Managing Gout: A Review of the Research for Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_consumer.pdf
     January 01, 2017 - Symptoms of a gout attack usually improve within about a week. But, an attack can happen again.

210. Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
     January 01, 2006 - children >14yrs and adults): 500mg initially, followed by 250 mg every 6 hours; use beyond one week … Exact Search Strings Ovid MEDLINE® searches (1966 to July Week 3 2005) I. … day naproxen 500 mg bid ibuprofen 800 mg tid 52 wks NR 1) paracetamol ≤2g/day 2) up to 2 two-week … Not reported 4,394 5 randomized, double-blind 12-week phase III trials; Three OA studies and 2 RA … Duration of trials 1 week to 2 years. Appendix F. Evidence Table 11[1].

211. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Lumacaftor/ivacaftor reportedly costs about $20,000 for a 4-week supply, or $260,000 per year. … Diffusion and cost: Lumacaftor/ivacaftor reportedly costs about $20,000 for a 4-week supply ($260,000 … In two replicate, phase III, randomized, double-blind, 52-week trials (INPULSIS-1 and INPULSIS-2), … It features nurse access 24 hours a day, 7 days a week, financial- support resources, and educational … Two 24-week phase 3 studies of lumacaftor in combination with ivacaftor met primary endpoint with

212. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
     January 24, 2022 - Participants were included up to the week where they reported having received their first dose of any

213. September 2021 Surveillance Report 1: Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-surveillance-report-1-updated_0.PDF
     December 01, 2021 - protocol 2 In brief, we searched Ovid® MEDLINE® through August 12, 2021, PsycINFO® through the second week

214. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - plus topiramate 92 mg Clinical trials: In 2013, Davidson and colleagues announced results of a 56-week … In 2011, Allison and colleagues had announced results from a 56-week clinical trial (EQUIP) evaluating … 2.1% in the placebo group (p<0.0001); in the ITT-LOCF analysis, LS mean percent weight loss at week … The 56-week completion rate was 72% and 64% for liraglutide 3 mg and placebo, respectively. … At week 52, patients in the lorcaserin group were again randomly assigned, receiving either lorcaserin

215. Appendix C: Fiber Intake and Laxation in People With Normal Bowel Function Report (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
     January 01, 2024 - depression, surgical treatment of obesity, abdominal surgery, >10 h of strenuous physical activity per week … RCT parallel <2020 No industry funding Reported (No COI) Community defecation frequency of ≤4 per week … regular menstrual cycles pregnant; not on western diet; history of antibiotic treatment for least 3 week … circumference >80 cm (females) and 92 cm (males), light physical activity level (less than 150 min/week … within three months prior to the study; use of probiotic, prebiotic, or synbiotic products > twice a week

216. Fiber-Intake-Final-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
     January 01, 2024 - circumference >80 cm (females) and 92 cm (males), light physical activity level (less than 150 min/week … within three months prior to the study; use of probiotic, prebiotic, or synbiotic products > twice a week … depression, surgical treatment of obesity, abdominal surgery, >10 h of strenuous physical activity per week … RCT parallel <2020 No industry funding Reported (No COI) Community defecation frequency of ≤4 per week … regular menstrual cycles pregnant; not on western diet; history of antibiotic treatment for least 3 week

217. Executive Summary_Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
     August 01, 2024 - Executive Summary_Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review Comparative Effectiveness Review Number 273 Treatment of Stages I–III Squamous Cell Anal Cancer: A Systematic Review Executive Summary Main Points • For the ini…

218. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
     January 01, 2007 - was more effective than placebo for the treatment of schizotypal personality disorder in one small 9-week … Aripiprazole was more effective than placebo for the treatment of borderline personality in one small 8-week

219. Disposition of Comments_Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disposition-comments.pdf
     April 10, 2025 - draft report is posted to the EHC Program website or AHRQ website for public comment for a 3- to 4-week … These can become a part of Physical education once or twice a week. LIFE STYLE MANAGEMENT. … detect post partum depression and should be given to parent to fill out during teh fisr 2 day or 2 week … taught , best practices enumerated 5th -12 th graders through PE class and science class twice a week

220. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
     August 01, 2022 - 2 hours; pain free, sustained pain free, and pain relief at 1 day; and sustained pain free at 1 week … Meta-analysis: lasmiditan vs. placebo for sustained pain free at 1 week ................ … ; 1 week to <2 weeks; 2 weeks to 4 weeks? … ; 1 week to <2 weeks; 2 weeks to 4 weeks? … ; 1 week to <2 weeks; 2 weeks to 4 weeks?